What Is N-of-One?
N-of-One is a ground-breaking model for personalized cancer care.
N-of-One—On the Leading Edge of a Revolution in Cancer Care
The treatment of cancer is in the midst of a revolution fueled by remarkable new advances in understanding the genetics and molecular biology of cancer. Central to these advances is the discovery that each patient's cancer has a specific genetic and molecular signature that may dramatically affect how it will respond to different treatments. This discovery has opened the door to a new approach to cancer treatment called molecular targeted therapy, which targets the specific genetic and molecular abnormalities responsible for the development and growth of a patient's cancer.
N-of-One harnesses this emerging science with an entirely new model of cancer care. Our team works with a network of state-of-the-art diagnostic laboratories, leading-edge research institutions, and top cancer experts to analyze each patient's tumor and, based on this information, identify the most advanced and effective treatment strategies available.
N-of-One—Making It Personal
Our company name—N-of-One—reflects our personalized strategy for cancer treatment. Standard treatment protocols focus on clinical results obtained from the study of large populations of relatively unselected patients (an "n" of many). In contrast, N-of-One focuses on diagnosis and treatment strategies tailored to each individual (an "n" of one), understanding as much as possible about that person's disease at the most fundamental level. Based on sophisticated genetic and molecular analyses of a patient's tumor, N-of-One brings to light information that helps patients and their physicians make the most-informed decisions.
N-of-One—Keeping It Independent and Unbiased
To serve cancer patients and their medical team with integrity, we do not profit from any laboratory testing, clinical trials, or referrals to cancer centers or members of our expert network.
